PolyMedica

PolyMedica Corporation, originally founded as Polymedica Industries, Inc., was a leading healthcare company that specialized in providing products and services for the management of chronic diseases. The company's most significant business unit was Liberty Medical, which became the largest direct-to-consumer provider of diabetes testing supplies in the United States. Initially focused on developing polymer-based medical devices for urology and wound care, PolyMedica successfully transitioned into a high-growth healthcare services model. In 2007, the company was acquired by Medco Health Solutions for approximately $1.5 billion, integrating its extensive diabetes management platform into Medco's pharmacy benefit management services. This acquisition solidified PolyMedica's legacy as a pioneer in the direct-to-consumer healthcare market.